INTERNATIONAL PATENT: HARPOON THERAPEUTICS, INC. FILES APPLICATION FOR "HER2 TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER"

GENEVA, Jan. 27 -- HARPOON THERAPEUTICS, INC. (126 East Lincoln AvenueRahway, New Jersey 07065) filed a patent application (PCT/US2025/037487) for "HER2 TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER" on Jul 14, 2025. With publication no. WO/2026/019685, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AUSTIN, Richard J. (1169 Guerrero StreetSan Francisco, California 94110), LEMON, Bryan D. (2493 Dell AvenueMountain View, California 94043), LIN, Shuoyen Jack (2350 Evergreen DriveSan Bruno, California 94066), WESCHE,...